Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Kathryn J. Aikin"'
Autor:
Caroline Rains, Kathryn J. Aikin, Helen W. Sullivan, Bridget J. Kelly, Shirley Liu, Camara Wooten, Jenna Brophy, Susana Peinado, Lauren McCormack, Sandra Crouse Quinn
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-16 (2024)
Abstract Background Under Sect. 564 of the Federal Food, Drug, and Cosmetic Act, when the US Department of Health and Human Services Secretary issues a declaration based on one of four types of determinations, FDA may authorize an unapproved product
Externí odkaz:
https://doaj.org/article/f391605836bd4c0cba8053bc5a16132d
Autor:
Christine Lee, Melanie J. McLean, Caroline J. Huang, Anh Nguyen Zarndt, Kathryn J. Aikin, Paula Rausch, Barbara R. Cohen, Janine Delahanty, Danielle M. Sholly, Wendy I. Slavit, Ewa D. Carlton
Publikováno v:
Journal of Primary Care & Community Health, Vol 12 (2021)
The U.S. encompasses a heterogenous mix of people and health disparities exist for various subpopulations, such as minorities, women, people with limited English proficiency, those with low socioeconomic status, and other underserved groups. Differen
Externí odkaz:
https://doaj.org/article/e6a3e020bea042fbaf5419c5fae70456
Autor:
Kathryn J. Aikin, Vanessa Boudewyns, Kevin R. Betts, Kristen C. Giombi, Ryan S. Paquin, Micaela Brewington, Raahina Malik
Publikováno v:
Health Communication. :1-14
Autor:
Jessica Thompson, Roberta C. Wines, Micaela Brewington, Karen Crotty, Kathryn J. Aikin, Helen Sullivan
Publikováno v:
Journal of Communication in Healthcare. :1-8
Autor:
Kathryn J. Aikin, Helen W. Sullivan, Andrew Caporaso, Victoria Hoverman, Ting Yan, Douglas Williams, Jennifer Crafts
Publikováno v:
Pharmacoepidemiology and Drug Safety. 32:312-320
FDA regulations state print ads for prescription drugs must provide a true statement of information "in brief summary" describing "side effects, contraindications and effectiveness." To fulfill these requirements, these ads typically display risk inf
Autor:
Kate Ferriola-Bruckenstein, Mihaela Johnson, Janice Tzeng, Ann Marie Trentacosti, Kathryn J. Aikin, Eric Brodsky, Helen Sullivan, Claudia Squire
Publikováno v:
Res Social Adm Pharm
Background The Prescribing Information (PI) is the US Food and Drug Administration (FDA)'s primary tool for communicating a summary of the essential scientific information needed for the safe and effective use of a prescription drug to healthcare pro
Autor:
Jessica Thompson, Molly Lynch, Helen W. Sullivan, Kathryn J. Aikin, Suzanne Dolina, Micaela Brewington
Publikováno v:
Therapeutic Innovation & Regulatory Science.
Publikováno v:
Health Mark Q
To fulfill a key regulation pertaining to prescription drug broadcast advertising, a common practice is to present the major risks along with “adequate provision” referencing several sources where audiences can obtain the full product labeling. I
Autor:
Kate Ferriola-Bruckenstein, Amie C. O’Donoghue, Victoria M. Scott, Ryan S. Paquin, Vanessa Boudewyns, Kathryn J. Aikin
Publikováno v:
Oncologist
Background Little is known about how physicians interpret data displays that depict preliminary or exploratory clinical data in physician-targeted sales aids for oncology drugs. Using three factorial experiments, we examined whether disclosures of da
Autor:
Douglas Rupert, Nicole Antoinette Mack, Alexander Rabre, Kathryn J. Aikin, Brian Southwell, Susana Peinado, HW Sullivan, Bridget Kelly, Mihaela Johnson, Sue West, Sarah Parvanta, Carla M. Bann
Publikováno v:
Res Social Adm Pharm
Purpose Understanding patient perceptions of prescription drug risks and benefits is an important component of determining risk-benefit tradeoffs and helping patients make informed medication decisions. However, few validated measures exist for captu